首页> 外文期刊>Polyhedron: The International Journal for Inorganic and Organometallic Chemistry >6- p-cymene) complexes bearing N-dibenzosuberenyl appended thiourea for catalytic transfer hydrogenation and in vitro anticancer activity]]>
【24h】

6- p-cymene) complexes bearing N-dibenzosuberenyl appended thiourea for catalytic transfer hydrogenation and in vitro anticancer activity]]>

机译:<![CDATA [半三明治RU(II)(η 6 - p -cymene)复合物轴承< Ce:斜体> n -dibenzosuberenyl附加硫脲催化转移氢化和体外>斜体>抗癌活动]]>

获取原文
获取原文并翻译 | 示例
           

摘要

Four Ru(II)(η6-p-cymene) complexes of the type [RuCl2(η6-p-cymene)L] (L?=?N-dibenzosuberenyl appended aroyl/acylthiourea ligand) (1–4) were synthesized and well characterized by elemental analyses, UV–Vis, FT-IR and NMR spectroscopic methods. The neutral monodentate S coordination of the ligand with Ru(II) ion was confirmed by the single crystal X-ray diffraction method. The catalytic transfer hydrogenation (TH) of the carbonyl and nitro compounds using 2-propanol (IPA) as a hydrogen source were tested with the prepared complexes. The TH reactions progressed with good conversions up to 99% and so the use of complex4was extended to aromatic/heterocyclic carbonyl and nitro compounds. In addition to this, the synthesized complexes were evaluated for theirin vitrocytotoxic activity against human cervical cancer (HeLa), human breast cancer (MCF-7) and human lung cancer (A549) cell lines. The complex2exhibited the most potent inhibitory activity against the three cancer cell lines MCF-7, A549, HeLa with IC50values of 18.91?±?0.97, 22.78?±?1.15 and 27.22?±?1.07?μM respectively, while maintaining low toxicity towards the non-cancer originated cell line HEK-293 (Human Embryonic Kidney 293).
机译:[RuCl 2(η6-癸丁烯)L](L≥α=β=α= N-二苯并苯基苯苯基苯基苯甲酰基芳酰基/酰基脲烯烯烯烯酯)(1-4)的四Ru(II)(η6-p-cymene)配合物得到合成,并良好以元素分析,UV-Vis,FT-IR和NMR光谱方法为特征。通过单晶X射线衍射法证实了用Ru(II)离子的配体的中性单常规S配位。用制备的配合物测试使用2-丙醇(IPA)作为氢气源的羰基和硝基化合物的催化转移氢化(Th)。该反应的进展良好的转化率高达99%,因此使用延伸到芳族/杂环羰基和硝基化合物的复合物4。除此之外,对人类宫颈癌(HELA),人乳腺癌(MCF-7)和人肺癌(A549)细胞系的挥霍细胞毒性活性评估合成的复合物。复杂的2.抑制对癌细胞系MCF-7,A549,HeLa的最有效的抑制活性,IC50值为18.91Ω·?0.97,22.78?±1.15和27.22?±1.07?μm,同时保持低毒性非癌症起源细胞系HEK-293(人胚胎肾293)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号